•
Dec 31, 2011

ResMed Q2 2012 Earnings Report

Total Revenue
$333M
Previous year: $306M
+8.7%
EPS
$0.42
Previous year: $0.39
+7.7%
Gross Profit
$199M
Previous year: $186M
+6.8%
Cash and Equivalents
$723M
Previous year: $616M
+17.4%
Free Cash Flow
$98.3M
Previous year: $50.5M
+94.6%
Total Assets
$2.04B
Previous year: $1.88B
+8.3%

ResMed

ResMed